Newsmakers

Quoin Pharmaceuticals (NASDAQ: QNRX) Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient

Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus […]

No Picture
Newsmakers

Innovation Beverage Group (NASDAQ: IBG) Expands U.S. Distribution of its Award-Winning Bitters Through One of the Nation’s Largest Beverage Alcohol Distributors

Republic National Distribution Company opens new distribution channels in six states including California, one of the largest markets in the U.S. SEVEN HILLS, AU  April 2, 2025 / Innovation Beverage Group Ltd (“IBG” or the “Company”) […]

Newsmakers

Predictive Oncology (NASDAQ: POAI) Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

Company successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core at the University of Michigan Tumor response models for novel compounds represent true drug discovery using Predictive’s active machine learning […]

Newsmakers

Tenon Medical (NASDAQ:TNON) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion

~ Achieves Significant Milestone with Expanded Use Indication, Opens Sizable New SI Market Opportunity ~ LOS GATOS, CA / March 24, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) (“Tenon” or the “Company”), a company transforming care […]

Newsmakers

Damon Inc. (NASDAQ: DMN) Announces Closing of Upsized $16.5 Million Underwritten Public Offering

Transaction Strengthens Balance Sheet and Enables Execution of Multi-Vertical Revenue Strategy VANCOUVER, BC, March 21, 2025 /PRNewswire/ – Damon Inc. (NASDAQ: DMN) (“Damon” or the “Company”), a designer and developer of electric motorcycles and other personal mobility […]

Newsmakers

Hyperfine (NASDAQ: HYPR) and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation

Collaboration aims to make portable MRI faster, smarter, and more accessible worldwide. GUILFORD, Conn., March 17, 2025—-Hyperfine, Inc. (NASDAQ: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered […]

Newsmakers

FDA Issues Clearance for ReWalk 7 Exoskeleton (NASDAQ: LFWD)

Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025  — Lifeward Ltd., (NASDAQ: LFWD) (“Lifeward” or the “Company”), a […]

Newsmakers

ImmunoPrecise (NASDAQ: IPA)Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.

Programs to be Driven Through Patented AI Technology and Advanced Proprietary B Cell Platforms Partnership advances next-generation ADCs and bispecific antibodies to address unmet medical needs AUSTIN, Texas, March 13, 2025—ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: […]

No Picture
Newsmakers

Plus Therapeutics (NASDAQ: PSTV) Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer

HOUSTON, March 06, 2025 — Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announces that the […]

No Picture
Newsmakers

BioXcel Therapeutics (NASDAQ: BTAI) Announces FDA Closed its Inspection of Site for Phase 3 TRANQUILITY II Trial for Acute Treatment of Agitation Associated with Alzheimer’s Dementia

FDA concludes site inspection is closed under 21 C.F.R.20.64(d)(3); Voluntary Action Indicated Company believes this further supports reliability of data from TRANQUILITY II trial of BXCL501 NEW HAVEN, Conn., March 03, 2025  — BioXcel Therapeutics, […]

Newsmakers

PepGen (NASDAQ: PEPG) Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights

– The Company today reported positive initial results from the ongoing FREEDOM-DM1 trial in patients with DM1; mean splicing correction of 12.3% and 29.1% in 5 and 10 mg/kg cohorts, respectively – – FREEDOM-DM1 15 […]

No Picture
Newsmakers

ScanTech AI (NASDAQ: STAI) Announces Initiative to Combat Contraband in Correctional Facilities Across the Americas

ScanTech AI is leading the charge in combating contraband in correctional facilities with cutting-edge artificial intelligence merged with advanced CT scanning technology Atlanta, GA, Feb. 18, 2025 — ScanTech AI Systems Inc. (NASDAQ: STAI) (“ScanTech […]